SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1399)1/16/2002 7:25:14 PM
From: arnie h  Read Replies (1) | Respond to of 10345
 
The Elan Q report rec'd today has this sentence "Products that do not meet these criteria ($100-500 Mil revenue) have been rationilised through a variety of structures from disposal to distribution agreements". Perhaps, Xcel is an example.



To: Icebrg who wrote (1399)1/17/2002 10:42:34 AM
From: porphyrin  Respond to of 10345
 
In the context of SSB role in xcel financing it is interesting to note that SSB upgraded ELN from hold to outperform today.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News